MGX 8-K: SEC filing
Filed with the SEC on · accession 0001193125-26-463400
MGX filed a 8-K (current report) with the SEC on Nov 16, 2026. Metagenomi Therapeutics furnished its November 2026 corporate presentation under Regulation FD disclosure (Item 7.01). The stock moved -4.7% by the first close after the filing.
Summary of the filing
Metagenomi Therapeutics furnished its November 2026 corporate presentation under Regulation FD disclosure (Item 7.01). The filing contains no material operational, financial, or corporate action announcements.
Key details
How MGX stock reacted
Close before
$0.69
Nov 13, 2026
First close after
-4.73%
$0.66
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MGX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MGX?
Click hereFrequently asked questions
What did MGX file with the SEC on Nov 16, 2026?
MGX filed a 8-K (SEC filing). Metagenomi Therapeutics furnished its November 2026 corporate presentation under Regulation FD disclosure (Item 7.01). The filing contains no material operational, financial, or corporate action announcements.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did MGX stock react to this filing?
MGX closed at $0.69 before the filing and $0.66 on Nov 16, 2026 (-4.73%).
Other MGX SEC filings
- 10-Q · SEC filingNov 10, 2026
- 8-K · SEC filingNov 10, 2026
- 8-K · SEC filingSep 22, 2026
- SCHEDULE 13G · SEC filingSep 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · SEC filingAug 10, 2026
- 8-K · Board changeJun 10, 2026
- 10-Q · SEC filingMay 11, 2026
- 8-K · SEC filingMay 11, 2026
- DEF 14A · Board changeApr 27, 2026
Get alerts when MGX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days